UnitedHealth Group Incorporated vs Vertex Pharmaceuticals Incorpor — Stock Comparison
UnitedHealth Group Incorporated (UNH) and Vertex Pharmaceuticals Incorpor (VRTX) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Vertex Pharmaceuticals Incorpor clearly outscores UnitedHealth Group Incorporated on Q·Score (8.5 vs 6.1 out of 10), led by Health (9.2 vs 5.3) and Quality (9.3 vs 5.9). UnitedHealth Group Incorporated scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for VRTX (+23.3%) than for UNH (-0.3%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
High-quality business with 24% return on equity and 36% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
UNH vs VRTX: which stock scores better overall?
Based on Q·Score, Vertex Pharmaceuticals Incorpor (VRTX) scores 8.5/10 versus UnitedHealth Group Incorporated (UNH) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: UNH or VRTX?
Vertex Pharmaceuticals Incorpor (VRTX) scores higher on Growth (7.4/10 vs 5.1/10). UnitedHealth Group Incorporated reports revenue growth (2.0% YoY) while Vertex Pharmaceuticals Incorpor reports (7.8% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is UNH or VRTX more attractively valued?
Vertex Pharmaceuticals Incorpor (VRTX) scores higher on Valuation (8.1/10 vs 6.5/10). UNH trades at 19.5× P/E versus VRTX at 20.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about UNH vs VRTX?
There are 26 analysts covering UNH with a consensus price target of $407.38, and 29 analysts covering VRTX with a consensus target of $548.69. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: UNH or VRTX?
Vertex Pharmaceuticals Incorpor (VRTX) scores higher on Quality (9.3/10 vs 5.9/10). Net profit margin: UNH at 2.7%, VRTX at 35.5%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: UNH or VRTX?
Vertex Pharmaceuticals Incorpor (VRTX) scores higher on Financial Health (9.2/10 vs 5.3/10). Market beta: UNH at 0.65, VRTX at 0.31. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of UNH and VRTX?
UnitedHealth Group Incorporated (UNH) has a market capitalisation of $371.0B, while Vertex Pharmaceuticals Incorpor (VRTX) has a market cap of $112.9B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do UNH or VRTX pay dividends?
UNH pays a dividend yield of 2.27%, while VRTX does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →